Literature DB >> 21828049

Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK).

Edward Thorp1, Tomas Vaisar, Manikandan Subramanian, Lauren Mautner, Carl Blobel, Ira Tabas.   

Abstract

Mer tyrosine kinase (MerTK) is an integral membrane protein that is preferentially expressed by phagocytic cells, where it promotes efferocytosis and inhibits inflammatory signaling. Proteolytic cleavage of MerTK at an unidentified site leads to shedding of its soluble ectodomain (soluble MER; sMER), which can inhibit thrombosis in mice and efferocytosis in vitro. Herein, we show that MerTK is cleaved at proline 485 in murine macrophages. Site-directed deletion of 6 amino acids spanning proline 485 rendered MerTK resistant to proteolysis and suppression of efferocytosis by cleavage-inducing stimuli. LPS is a known inducer of MerTK cleavage, and the intracellular signaling pathways required for this action are unknown. LPS/TLR4-mediated generation of sMER required disintegrin and metalloproteinase ADAM17 and was independent of Myd88, instead requiring TRIF adaptor signaling. LPS-induced cleavage was suppressed by deficiency of NADPH oxidase 2 (Nox2) and PKCδ. The addition of the antioxidant N-acetyl cysteine inhibited PKCδ, and silencing of PKCδ inhibited MAPK p38, which was also required. In a mouse model of endotoxemia, we discovered that LPS induced plasma sMER, and this was suppressed by Adam17 deficiency. Thus, a TRIF-mediated pattern recognition receptor signaling cascade requires NADPH oxidase to activate PKCδ and then p38, culminating in ADAM17-mediated proteolysis of MerTK. These findings link innate pattern recognition receptor signaling to proteolytic inactivation of MerTK and generation of sMER and uncover targets to test how MerTK cleavage affects efferocytosis efficiency and inflammation resolution in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828049      PMCID: PMC3190938          DOI: 10.1074/jbc.M111.263020

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs).

Authors:  J David Becherer; Carl P Blobel
Journal:  Curr Top Dev Biol       Date:  2003       Impact factor: 4.897

2.  Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor α and growth arrest-specific gene 6.

Authors:  Xueying Feng; Tingting Deng; Yue Zhang; Shaobo Su; Chiju Wei; Daishu Han
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

3.  Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.

Authors:  Z Zhang; P Oliver; J R Lancaster; P O Schwarzenberger; M S Joshi; J Cork; J K Kolls
Journal:  FASEB J       Date:  2000-12-08       Impact factor: 5.191

4.  Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk.

Authors:  D Vollrath; W Feng; J L Duncan; D Yasumura; P M D'Cruz; A Chappelow; M T Matthes; M A Kay; M M LaVail
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

5.  Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.

Authors:  P Reddy; J L Slack; R Davis; D P Cerretti; C J Kozlosky; R A Blanton; D Shows; J J Peschon; R A Black
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

6.  Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa.

Authors:  A Gal; Y Li; D A Thompson; J Weir; U Orth; S G Jacobson; E Apfelstedt-Sylla; D Vollrath
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.

Authors:  B Hurtado; X Muñoz; P Recarte-Pelz; N García; A Luque; J Krupinski; N Sala; P García de Frutos
Journal:  Thromb Haemost       Date:  2011-03-08       Impact factor: 5.249

8.  Phagocytosis and clearance of apoptotic cells is mediated by MER.

Authors:  R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima
Journal:  Nature       Date:  2001-05-10       Impact factor: 49.962

9.  Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.

Authors:  Elena Díaz-Rodríguez; Juan Carlos Montero; Azucena Esparís-Ogando; Laura Yuste; Atanasio Pandiella
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

10.  Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.

Authors:  Philip L Cohen; Roberto Caricchio; Valsamma Abraham; Todd D Camenisch; J Charles Jennette; Robert A S Roubey; H Shelton Earp; Glenn Matsushima; Elizabeth A Reap
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  120 in total

1.  Heart disease: Death-defying plaque cells.

Authors:  Ira Tabas
Journal:  Nature       Date:  2016-07-20       Impact factor: 49.962

Review 2.  Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.

Authors:  Katey J Rayner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07       Impact factor: 8.311

3.  Cardiomyocytes induce macrophage receptor shedding to suppress phagocytosis.

Authors:  Shuang Zhang; Xin-Yi Yeap; Lubov Grigoryeva; Shirley Dehn; Matthew DeBerge; Michael Tye; Emily Rostlund; Dorien Schrijvers; Zheng Jenny Zhang; Ronen Sumagin; Warren G Tourtellotte; Daniel Lee; Jon Lomasney; John Morrow; Edward B Thorp
Journal:  J Mol Cell Cardiol       Date:  2015-08-24       Impact factor: 5.000

Review 4.  The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.

Authors:  Bridget Shafit-Zagardo; Ross C Gruber; Juwen C DuBois
Journal:  Pharmacol Ther       Date:  2018-03-04       Impact factor: 12.310

5.  Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.

Authors:  Elaine Wan; Xin Yi Yeap; Shirley Dehn; Rachael Terry; Margaret Novak; Shuang Zhang; Shinichi Iwata; Xiaoqiang Han; Shunichi Homma; Konstantinos Drosatos; Jon Lomasney; David M Engman; Stephen D Miller; Douglas E Vaughan; John P Morrow; Raj Kishore; Edward B Thorp
Journal:  Circ Res       Date:  2013-07-08       Impact factor: 17.367

Review 6.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

7.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

8.  Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.

Authors:  Will S Driscoll; Tomas Vaisar; Jingjing Tang; Carole L Wilson; Elaine W Raines
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

9.  Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Authors:  Saranga Sriranganathan; Elena Tutunea-Fatan; Alina Abbasi; Lakshman Gunaratnam
Journal:  Mol Cell Biochem       Date:  2020-11-19       Impact factor: 3.396

10.  MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.

Authors:  Bishuang Cai; Edward B Thorp; Amanda C Doran; Manikandan Subramanian; Brian E Sansbury; Chyuan-Sheng Lin; Matthew Spite; Gabrielle Fredman; Ira Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.